Celltrion Chairman Seo Jung-jin sees US drug price cuts as an opportunity, maintains 5 trillion won sales target, and plans to decide on US factory by year-end.
#YonhapInfomax #Celltrion #DrugPriceCuts #Biosimilars #USTariffs #CDMOFactory #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63348